Aspen Neuroscience Prices IPO at $15 per Share (ASPE:Pending)

Aspen Neuroscience prices IPO at $15 per share (ASPE:Pending)

Aspen Neuroscience (ASPE) priced its IPO of 9.375M shares at $15 per share, expecting gross proceeds of ~$140.6M.

Aspen Neuroscience Prices IPO at $15 a Share in 9.375 Million-Share Offering

The offering is expected to generate about $140.6 million in gross proceeds. Underwriters have 30 days to buy up to 1,406,250 additional shares.

Aspen Neuroscience lands $141M IPO, while Bambusa secures $169M

A Parkinson's cell therapy biotech and an I&I startup from former BioNTech leaders will join the public markets on Friday, extending a sizzling IPO streak for drug developers. Aspen Neuroscience will collect ...

Aspen Neuroscience Announces Pricing of Initial Public Offering

SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative